Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-23T08:33:14.366Z Has data issue: false hasContentIssue false

Pseudocholinesterase Activity and Phenotypes in Mentally Ill Patients

Published online by Cambridge University Press:  29 January 2018

David N. Propert*
Affiliation:
University of Melbourne Department of Psychiatry, Royal Melbourne Hospital, Victoria 3050, Australia

Summary

Pseudocholinesterase activities and phenotypes have been determined in 103 affectively ill patients, 168 schizophrenics and 73 Huntington's disease sufferers and compared with those of a sample of healthy controls. The distributions of phenotypes in the patient samples did not differ significantly from those of the controls.

When corrections were made for sex, age and E1 phenotypes, the Huntington's disease patients showed a reduced level of cholinesterase activity. Normal levels were found in affective disorders and schizophrenia.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 1979 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Antebi, R. N. & King, J. (1962) Serum enzyme activity in chronic schizophrenia. Journal of Mental Science, 108, 75–9.CrossRefGoogle ScholarPubMed
Berry, M. & Whittaker, M. (1975) Incidence of suxamethonium apnoea in patients undergoing E.C.T. British Journal of Anaesthesia, 47, 1195–7.Google Scholar
Brackenridge, C. J., Case, J., Chiu, E., Propert, D. N., Teltscher, B. & Wallace, D. C. (1978) A linkage study of the loci for Huntington's disease and some common polymorphic markers. Annals of Human Genetics (in press).CrossRefGoogle Scholar
Domino, E. F., Krause, R. R., Thiessen, M. M. & Basakis, J. G. (1975) Blood protein fraction comparisons of normal and schizophrenic patients. Archives of General Psychiatry, 32, 717–21.Google Scholar
Harris, H. & Whittaker, M. (1961) Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes. Nature, London, 191, 496–8.Google Scholar
Jones, M. S. & Stadie, W. (1939) The choline esterase content of the muscle of myasthenia gravis and of the serum of four other groups of clinical conditions. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences, 29, 63–7.CrossRefGoogle Scholar
Kalow, W. & Genest, K. (1957) A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Canadian Journal of Biochemistry and Physiology, 35, 339–46.Google Scholar
Kalow, W. & Gunn, D. R. (1959) Some statistical data on atypical cholinesterase of human serum. Annals of Human Genetics, 23, 239–50.CrossRefGoogle ScholarPubMed
Kalow, W. & Lindsay, H. A. (1955) A comparison of optical and manometric methods for the assay of human serum cholinesterase. Canadian Journal of Biochemistry and Physiology, 33, 568–74.Google Scholar
Kalow, W. & Staron, N. (1957) On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Canadian Journal of Biochemistry and Physiology, 35, 1305–20.Google Scholar
Liddell, J., Lehmann, H. & Silk, E. (1962) A ‘silent’ pseudocholinesterase gene. Nature, London, 193, 561–2.Google Scholar
McComb, R. B., LaMotta, R. V. & Wetstone, H. J. (1964) Studies of cholinesterase activity. VII. Kinetic constants of serum cholinesterase in normal populations and those with neoplasms. Journal of Laboratory and Clinical Medicine, 63, 827–37.Google ScholarPubMed
Milstoc, M., Teoduru, C. V., Fieve, R. R. & Kumbaraci, T. (1975) Cholinesterase activity and manic depressive patients. Diseases of the Nervous System, 36, 197–9.Google Scholar
Perris, C. (Ed.) (1966) A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatrica Scandinavica, 42, Supp. 194.Google Scholar
Plum, C. M. (1960) Study of cholinesterase activity in nervous and mental disorders. Clinical Chemistry, 6, 332–40.CrossRefGoogle ScholarPubMed
Propert, D. N. & Brackenridge, C. J. (1976) The relation of sex, age, smoking status, birth rank and parental ages to pseudocholinesterase activity and phenotypes in a sample of Australian Caucasian adults. Human Genetics, 32, 181–8.CrossRefGoogle Scholar
Richter, D. & Lee, M. (1942a) Serum choline esterase and anxiety. Journal of Mental Science, 88, 428–34.Google Scholar
Richter, D. & Lee, M. (1942b) Serum choline esterase and depression. Journal of Mental Science, 88, 435–9.Google Scholar
Rose, L., Davies, D. A. & Lehmann, H. (1965) Serumpseudocholinesterase in depression with notable anxiety. Lancet, ii, 563–5.Google Scholar
Tod, H. & Jones, M. S. (1937) A study of the choline esterase activity in nervous and mental disorders. Quarterly Journal of Medicine, 6, 13.Google Scholar
Wetstone, H. J., LaMotta, R. V., Bellucci, A., Tennant, R. & White, B. V. (1960) Studies of cholinesterase activity. V. Serum cholinesterase in patients with carcinoma. Annals of Internal Medicine, 52, 102–25.Google ScholarPubMed
Whittaker, M. & Berry, M. (1977) The plasma cholinesterase variants in mentally ill patients. British Journal of Psychiatry, 130, 397404.CrossRefGoogle ScholarPubMed
Whittaker, M. & Spencer, R. (1977) Plasma cholinesterase variants in patients having lithium therapy. Clinica Chimica Acta, 75, 421–5.Google Scholar
Winokur, G. (1975) Paranoid vs hebephrenic schizophrenia: Clinical and familial (genetic) heterogeneity. Psychopharmacology Communications, 1, 567–77.Google Scholar
Winokur, G., Morrison, J., Clancy, J. & Crowe, R. (1974) Iowa 500: The clinical and genetic distinction of hebephrenic and paranoid schizophrenia. Journal of Nervous and Mental Disease, 159, 12–9.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.